Then, we compared the enrichment efficiency using rare tumor cells to mimic clinical samples (rare FRα highly expressing SPC-A-1 and H157 NSCLC cells were spiked into healthy donors’ blood). This evidence concerns the gene FOLR1 and neoplasm.